Page 96 - Pharmacy Appeals 1/4/04 to 31/3/05

72 Corporate governance report

Compliance with the corporate Committees of the Board
governance code
The Board is supported by four committees established
While we are not required to comply with the UK to enable the Board, and me as Accounting Officer,
Code of Corporate Governance the Board and to discharge our responsibilities and to ensure
its committees have due regard to the principles that effective financial stewardship and internal
set out in the Code. Effectiveness reviews of the controls are in place. A review of the terms of
Board and ARC take the Code into account. reference for the three committees was carried out
in 2021/22 to assure their fitness for purpose.
Board effectiveness
Audit and Risk Committee
A Board effectiveness self-assessment was carried out
in 2021. The 2021 review was also informed by a look The ARC supports the Board and me in our responsibilities
back on the content of the Board meetings referenced on matters related to internal and external audit,
against a number of sources including the following: corporate governance, anti-fraud policies, internal
control and risk management, and NEIS Resolution's
• HM Treasury: Corporate governance in central
annual report and accounts. The ARC is chaired by a
government departments: Code of good practice
non-executive director and is supported in delivery of its
• NAO Board Evaluation Questionnaire in line with function by internal and external auditors. The Chair of
Corporate governance in central government the DEISC ARC attended the ARC meeting in June 2021.
departments: Code o f good practice (updated 2017).
ARC has two independent lay members.
Following the self-assessment, we have concluded that

During the period of 1 April 2021 to 31 March
the Board is fulfilling and discharging its responsibilities
2022 the committee met on four occasions.
effectively and there are no significant gaps.
Attendance by members was as follows.
The Board have agreed that, given the change in Chair
and non-executive director membership, an independent
effectiveness review will be carried out in 2022/23
which will also encompass the Board sub-committees.

Table 11: Audit and Risk Committee meeting attendance

Name Post Meetings
attended

Charlotte Moar Non-executive Director and Chair of ARC 4/4

Mike Pinkerton* Non-executive Director 3/3
Charles Bellringer Independent Lay Member 4/4

Julia Wortley Independent Lay Member 4/4

* Mike Pinkerton attended the February 2022 ARC meeting as NEIS Resolution Interim Chair.